These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 9701397)
1. Light scatter and immunophenotypic characteristics of blast cells in typical acute promyelocytic leukemia and its variant. Piedras J; López-Karpovitch X; Cárdenas R Cytometry; 1998 Aug; 32(4):286-90. PubMed ID: 9701397 [TBL] [Abstract][Full Text] [Related]
2. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement. Rizzatti EG; Portieres FL; Martins SL; Rego EM; Zago MA; Falcão RP Am J Hematol; 2004 May; 76(1):44-51. PubMed ID: 15114596 [TBL] [Abstract][Full Text] [Related]
3. The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34 CD2 hypergranular (M3) and microgranular (M3v) phenotypes. Albano F; Mestice A; Pannunzio A; Lanza F; Martino B; Pastore D; Ferrara F; Carluccio P; Nobile F; Castoldi G; Liso V; Specchia G Haematologica; 2006 Mar; 91(3):311-6. PubMed ID: 16531253 [TBL] [Abstract][Full Text] [Related]
4. Acute promyelocytic leukemia: four distinct patterns by flow cytometry immunophenotyping. Gorczyca W Pol J Pathol; 2012 Mar; 63(1):8-17. PubMed ID: 22535601 [TBL] [Abstract][Full Text] [Related]
5. The flow cytometric pattern of CD34, CD15 and CD13 expression in acute myeloblastic leukemia is highly characteristic of the presence of PML-RARalpha gene rearrangements. Orfao A; Chillón MC; Bortoluci AM; López-Berges MC; García-Sanz R; Gonzalez M; Tabernero MD; García-Marcos MA; Rasillo AI; Hernández-Rivas J; San Miguel JF Haematologica; 1999 May; 84(5):405-12. PubMed ID: 10329918 [TBL] [Abstract][Full Text] [Related]
6. Immunophenotypic pattern of myeloid populations by flow cytometry analysis. Gorczyca W; Sun ZY; Cronin W; Li X; Mau S; Tugulea S Methods Cell Biol; 2011; 103():221-66. PubMed ID: 21722806 [TBL] [Abstract][Full Text] [Related]
7. HLA-DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia. Oelschlaegel U; Mohr B; Schaich M; Schäkel U; Kroschinsky F; Illmer T; Ehninger G; Thiede C Cytometry B Clin Cytom; 2009 Sep; 76(5):321-7. PubMed ID: 19291801 [TBL] [Abstract][Full Text] [Related]
8. Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party. Allford S; Grimwade D; Langabeer S; Duprez E; Saurin A; Chatters S; Walker H; Roberts P; Rogers J; Bain B; Patterson K; McKernan A; Freemont P; Solomon E; Burnett A; Goldstone A; Linch D Br J Haematol; 1999 Apr; 105(1):198-207. PubMed ID: 10233384 [TBL] [Abstract][Full Text] [Related]
9. The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): does it prove true for the M3-variant? Exner M; Thalhammer R; Kapiotis S; Mitterbauer G; Knöbl P; Haas OA; Jäger U; Schwarzinger I Cytometry; 2000 Apr; 42(2):106-9. PubMed ID: 10797447 [TBL] [Abstract][Full Text] [Related]
10. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia]. Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475 [TBL] [Abstract][Full Text] [Related]
11. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis. Klobusicka M; Kusenda J; Babusikova O Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082 [TBL] [Abstract][Full Text] [Related]
12. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis. Lin P; Hao S; Medeiros LJ; Estey EH; Pierce SA; Wang X; Glassman AB; Bueso-Ramos C; Huh YO Am J Clin Pathol; 2004 Mar; 121(3):402-7. PubMed ID: 15023045 [TBL] [Abstract][Full Text] [Related]
13. [Immunophenotypic features of acute myeloid leukemia with AML-1/ETO fusion gene]. Zhang JJ; DU X; Huang ZX; Su JH; Zhou MH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):378-81. PubMed ID: 17493351 [TBL] [Abstract][Full Text] [Related]
14. AML M3 and AML M3 variant each have a distinct gene expression signature but also share patterns different from other genetically defined AML subtypes. Haferlach T; Kohlmann A; Schnittger S; Dugas M; Hiddemann W; Kern W; Schoch C Genes Chromosomes Cancer; 2005 Jun; 43(2):113-27. PubMed ID: 15751046 [TBL] [Abstract][Full Text] [Related]
16. Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia. Hoffmann MH; Klausen TW; Boegsted M; Larsen SF; Schmitz A; Leinoe EB; Schmiegelow K; Hasle H; Bergmann OJ; Sorensen S; Nyegaard M; Dybkaer K; Johnsen HE Cytometry B Clin Cytom; 2012 May; 82(3):123-31. PubMed ID: 22328535 [TBL] [Abstract][Full Text] [Related]
17. Correlation between morphological and cytochemical heterogeneity of acute promyelocytic leukemia (APL) and its association with myelodysplasia. Varma N; Dash S; Sarode R Indian J Cancer; 1990 Sep; 27(3):165-71. PubMed ID: 2090569 [TBL] [Abstract][Full Text] [Related]